AI is not overhyped. The potential requires equal attention to the less glamorous but more important role of data management.
Drug discovery demands speed and precision, with success often hinging on how quickly teams can move compounds through synthesis, purification, and testing. In this project, flexibility and agility ...
In December, The Conversation hosted a webinar on AI's revolutionary role in drug discovery and development. Science and ...
Advances in AI-Driven Drug Discovery ONLINE explores how pharma leaders are implementing AI across the pipeline.
1910 is on a mission to “make undruggable targets a thing of the past” by “turning every pharma company into an AI company,” says founder and CEO, Jen Asher, PhD. The Sam Altman–backed AI drug ...
Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...
Variational AI applies its 𝐄𝐧𝐤𝐢™ generative AI platform to design novel PRMT6 inhibitor scaffolds and discover lead candidates. To ensure rapid execution and reduce downstream attrition, the ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Modern Medical Research Laboratory. Scientific Lab, Drug Engineering Center Full of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results